Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CSPC Aonuo (China) Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development and manufacture of pediatric and nutritional health products. The company is best known for its flagship product, Zinc Gluconate and Calcium Gluconate Oral Solution, which is a market leader in the Chinese pediatric calcium and zinc supplement segment. Founded in 1996 and headquartered in Qinhuangdao, Aonuo was acquired by CSPC Pharmaceutical Group in 2019 to strengthen its presence in the over-the-counter (OTC) and pediatric markets. The company operates large-scale GMP-certified manufacturing facilities and maintains a robust distribution network across China. Its product portfolio focuses on addressing nutritional deficiencies through high-quality oral formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 澳诺.